Copyright: ©Author(s) 2026.
World J Clin Pediatr. Dec 9, 2026; 15(4): 117885
Published online Dec 9, 2026. doi: 10.5409/wjcp.117885
Published online Dec 9, 2026. doi: 10.5409/wjcp.117885
Table 2 Management and outcomes
| Parameter | Median (interquartile range) or n (%) |
| Thoracentesis | 5 (50) |
| Pleural drainage placement | 7 (70) |
| Duration (days) | 15 (11-21) |
| Octreotide | 5 (50) |
| Octreotide, start day | 18 (14-20) |
| Octreotide, stop day | 50 (39-85) |
| Duration (days) | 29 (24-35) |
| Octreotide, start dose (μg/kg/hour) | 2 (1-4) |
| Octreotide, highest dose (μg/kg/hour) | 12 (9-17) |
| Parenteral nutrition (days) | 27 (11-42) |
| Start enteral nutrition (days) | 18 (8-27) |
| Start breast milk (days) | 38 (33-45) |
| Recurrence | 1 (10) |
| Survival | 9 (90) |
- Citation: Perri A, Sbordone A, Fattore S, De Matteis A, Rotunno G, Marrocco GA, Nobile S, Giordano L, Tana M, Vento G. Neonatal chylothorax and ultrasound: Diagnosis, measurements, and correlations with management. World J Clin Pediatr 2026; 15(4): 117885
- URL: https://www.wjgnet.com/2219-2808/full/v15/i4/117885.htm
- DOI: https://dx.doi.org/10.5409/wjcp.117885